UPDATE 1-Lilly's lupus treatment succeeds in mid-stage trial
June 13, 2018 at 15:51 PM EDT
June 13 (Reuters) - Eli Lilly & Co said on Wednesday its drug to treat autoimmune disease lupus met the main goal of a mid-stage trial, positioning the drugmaker to begin a bigger study later this year.
